Clinical Orthopaedics and Related Research®

, Volume 471, Issue 8, pp 2684–2690

Malignant Lymphoma of Bone: A Review of 119 Patients

  • Emre Demircay
  • Francis John HornicekJr
  • Henry J. Mankin
  • Henry DegrootIII
Clinical Research

DOI: 10.1007/s11999-013-2991-x

Cite this article as:
Demircay, E., Hornicek, F.J., Mankin, H.J. et al. Clin Orthop Relat Res (2013) 471: 2684. doi:10.1007/s11999-013-2991-x



Lymphoma of bone is uncommon. As a result of this, many aspects of primary lymphoma of bone (PLB) are controversial: the definition, treatment strategies, response criteria, and prognostic factors.


We sought to determine the following in an analysis from a single center over a four-decade period: (1) 5-year disease-free survival of patients with PLB as well as those with systemic lymphoma with bone involvement; and (2) whether prognostic factors (sex, site of tumor, age) were associated with 5-year survival.


A total of 119 patients with lymphoma involving the musculoskeletal system were retrospectively evaluated. Among these, 94 patients who had a minimum followup of 6 months (mean, 67 months; range, 6 months to 34 years) were further analyzed for the skeletal site of involvement, the orthopaedic intervention(s) needed, and survival. The overall median age was 45 years (range, 7–87 years). The female-to-male ratio was 1:1.53. There were 70 (65 unifocal, five multifocal) patients with PLB. The femur was the most frequent site involved. Appendicular skeleton involvement was substantially higher in patients with PLB. Thirty-four (36%) patients had at least one surgical intervention. Fourteen patients (41%) needed more than one major surgical intervention.


The disease-free 5-year survival for patients with PLB was 81% and for the patients with systemic lymphoma with bone involvement, it was 44%. The disease-free 5-year survival of the patients with PLB younger than 60 years old and 60 years old or older was 90% and 62%, respectively. Age was the only prognostic factor on survival of patients with PLB.


Orthopaedic intervention was usually needed for pathologic fractures, avascular necrosis, spinal cord compression, or for the lesions of the weightbearing bones compromising stability or joint motion. The potential for long-term survival suggests the use of implants and techniques that have the best chance of long-term success.

Level of Evidence

Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Copyright information

© The Association of Bone and Joint Surgeons® 2013

Authors and Affiliations

  • Emre Demircay
    • 1
  • Francis John HornicekJr
    • 2
  • Henry J. Mankin
    • 3
  • Henry DegrootIII
    • 4
  1. 1.Department of Orthopedic SurgeryBaskent University School of MedicineIstanbulTurkey
  2. 2.Harvard Medical School, Orthopaedic Oncology, Massachusetts General HospitalBostonUSA
  3. 3.Harvard Medical SchoolBostonUSA
  4. 4.Newton-Wellesley HospitalNewton Lower FallsUSA